FDA Approves First Dermal Filler To Treat Acne Scarring

Posted on January 6th, 2017 by amy87h10126555

(Reuters) – The U.S. Food and Drug Administration approved the first dermal filler to treat scarring caused by acne, the most common skin disorder in the United States afflicting 40-50 million people. Bellafill, developed by privately held Suneva Medical Inc, has been developed to treat moderate to severe acne scars on the cheeks of patients […]

Read More